Hyperion DeFi (HYPD)

Crypto Stocks
Hyperion DeFi
Thu, 6/11/2026, 06:33:20 AM
logo
Hyperion DeFi
NASDAQ · $HYPD
Crypto Strategic Reserve
$2.515
-3.08%
Company Information
Hyperion DeFi, Inc. is an ophthalmic technology company dedicated to developing and selling ophthalmic solutions in the United States. The company offers the Optejet platform service for the local delivery of ophthalmic drugs. The company has entered into licensing agreements with Bausch Health Ireland Limited to develop and sell MicroPine in the United States and Canada; with Arctic Vision (Hong Kong) Limited to develop and sell MicroPine, MicroLine, and Mydcombi in China and South Korea; with Kaken Pharmaceutical Co., Ltd. to develop and sell MicroPine, MicroLine, and Mydcombi; and with Formosa Pharmaceuticals, Inc. to co-develop a 0.05% clobetasol propionate ophthalmic suspension for the treatment of acute dry eye in the United States. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is headquartered in New York City, New York.
Coin Reserve Status
HYPE
币种储备情况
As of July 2025, Hyperion DeFi holds 1,427,178 HYPE tokens, with an average purchase cost of $35.38 per token.
Long press to scan QR code for more content
Hyperion DeFi

Hyperion DeFi

$HYPDNASDAQ
Crypto Strategic Reserve

Company Information

Hyperion DeFi, Inc. is an ophthalmic technology company dedicated to developing and selling ophthalmic solutions in the United States. The company offers the Optejet platform service for the local delivery of ophthalmic drugs. The company has entered into licensing agreements with Bausch Health Ireland Limited to develop and sell MicroPine in the United States and Canada; with Arctic Vision (Hong Kong) Limited to develop and sell MicroPine, MicroLine, and Mydcombi in China and South Korea; with Kaken Pharmaceutical Co., Ltd. to develop and sell MicroPine, MicroLine, and Mydcombi; and with Formosa Pharmaceuticals, Inc. to co-develop a 0.05% clobetasol propionate ophthalmic suspension for the treatment of acute dry eye in the United States. The company was formerly known as Eyenovia, Inc. and changed its name to Hyperion DeFi, Inc. in July 2025. Hyperion DeFi, Inc. was founded in 2014 and is headquartered in New York City, New York.
CEO
Michael M. Rowe
Founded
2025
Headquarters
New York City, New York State
EXCHANGE
NASDAQ
H
Annual High
$4.78
L
Annual Low
$2.51

Stock Chart

Business Model

Business Mode

The core business of Hyperion DeFi revolves around the HYPE token, aiming to become the first publicly listed company in the United States to provide compliant investment channels for investors through holding HYPE tokens and participating in the Hyperliquid protocol. The company continues to increase its holdings of HYPE tokens and plans to deploy them on the HyperCore and HyperEVM platforms to create potential revenue sources. Additionally, the company has partnered with Kinetiq to launch co-branded validation nodes on the Hyperliquid blockchain, utilizing HYPE tokens to ensure network security.

Profit Model

Hyperion DeFi profits by using reserved HYPE tokens for staking, lending, expanding node operations, and earning referral commissions. At the same time, as the value of HYPE tokens increases, the value of the assets held by the company will also rise, which can be profited from by timely selling a portion of the tokens. Additionally, as a publicly listed company, an increase in stock price can enhance the company's market value, attracting more investors and providing more funds for increasing HYPE token holdings, creating a virtuous cycle.

Profit Model Impact

This profit model helps Hyperion DeFi establish a competitive advantage in the cryptocurrency field. By participating in the operation of the Hyperliquid ecosystem, it can obtain a stable source of income, thereby enhancing the company's profitability. At the same time, it also provides investors with a compliant investment channel for cryptocurrency assets, which is beneficial for attracting more institutional investors, connecting traditional capital markets with decentralized finance, and promoting the compliant development and popularization of the cryptocurrency industry.

Impact on Cryptocurrencies

The main impact is reflected in the HYPE token. The company's continuous accumulation of HYPE tokens will increase market demand and drive up its price. In addition, the company utilizes HYPE for services such as staking and lending, expanding its application scenarios within the ecosystem, further enhancing the value and market influence of HYPE. At the same time, the company's compliant operations and market influence may also attract more investors' attention to the Hyperliquid protocol, indirectly promoting the development of the HYPE token.